The recommendation is Overweight (BUY), implemented via a phased approach due to overbought conditions at entry. Initiate a half-sized core position at $222.50 (1.5–2% of portfolio) with a hard stop at $194.84 (50 SMA), reserving dry powder for $208–213 add tranches on pullback, and reserving full target weight (3–4%) only on confirmed hold above the 50 SMA with MACD re-acceleration. Structural conviction (Q2 +14.5% revenue, +31% operating income, $8B debt reduction, multiple catalysts) supports meaningful exposure, but the entry point—overbought RSI 75.95, declining MACD histogram, lowest-volume buying climax—warrants the phased approach over full commitment.